Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of Incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/CAAC.21660.

Article  PubMed  Google Scholar 

Devi BCR, Tang TS, Corbex M. Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia. Ann Oncol. 2007;18(7):1172–6. https://doi.org/10.1093/ANNONC/MDM105.

Article  CAS  PubMed  Google Scholar 

Kunda J, et al. Health-seeking behaviour of human brucellosis cases in rural Tanzania. BMC Public Health. 2007;7(1):1–7. https://doi.org/10.1186/1471-2458-7-315/TABLES/2.

Article  Google Scholar 

Hicks ML, Yap OWS, Matthews R, Parham G. Disparities in cervical cancer screening, treatment and outcomes. Ethn Dis. 2006;16(2 Suppl 3):63–6.

Google Scholar 

Thomson CS, Forman D. Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results? Br J Cancer. 2009;S101:S102-109. https://doi.org/10.1038/SJ.BJC.6605399.

Article  Google Scholar 

Gizaw M, et al. Cervical cancer patients presentation and survival in the only oncology referral hospital, Ethiopia: a retrospective cohort study. Infect Agent Cancer. 2017. https://doi.org/10.1186/S13027-017-0171-4.

Article  PubMed  PubMed Central  Google Scholar 

Waggoner SE. Cervical cancer. Lancet. 2003;361(9376):2217–25. https://doi.org/10.1016/S0140-6736(03)13778-6.

Article  PubMed  Google Scholar 

Vinh-Hung V, et al. Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer. 2007;7:1–13. https://doi.org/10.1186/1471-2407-7-164.

Article  Google Scholar 

Kantelhardt EJ, et al. Cervical cancer in Ethiopia: survival of 1,059 patients who received oncologic therapy. Oncologist. 2014;19(7):727–34. https://doi.org/10.1634/THEONCOLOGIST.2013-0326.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen CP, Kung PT, Wang YH, Tsai WC. Effect of time interval from diagnosis to treatment for cervical cancer on survival: a nationwide cohort study. PLoS ONE. 2019;14(9): e0221946. https://doi.org/10.1371/JOURNAL.PONE.0221946.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma J, et al. Effect of socio-economic factors on delayed access to health care among Chinese cervical cancer patients with late rectal complications after radiotherapy. Gynecol Oncol. 2012;124(3):395–8. https://doi.org/10.1016/J.YGYNO.2011.11.040.

Article  PubMed  Google Scholar 

Brewer N, Pearce N, Jeffreys M, White P, Ellison-Loschmann L. Demographic differences in stage at diagnosis and cervical cancer survival in New Zealand, 1994–2005. J Womens Health. 2009;18(7):955–63. https://doi.org/10.1089/JWH.2008.1163.

Article  Google Scholar 

Yu CK, Chiu C, McCormack M, Olaitan A. Delayed diagnosis of cervical cancer in young women. J Obstet Gynaecol. 2005;25(4):367–70. https://doi.org/10.1080/01443610500118814.

Article  CAS  PubMed  Google Scholar 

Ibfelt E, et al. Socioeconomic position and stage of cervical cancer in Danish women diagnosed 2005–2009. Cancer Epidemiol Biomarkers Prev. 2012;21(5):835–42. https://doi.org/10.1158/1055-9965.EPI-11-1159.

Article  PubMed  Google Scholar 

Hansen RP, Olesen F, Sørensen HT, Sokolowski I, Søndergaard J. Socioeconomic patient characteristics predict delay in cancer diagnosis: a Danish cohort study. BMC Health Serv Res. 2008;8:1–10. https://doi.org/10.1186/1472-6963-8-49.

Article  Google Scholar 

Arndt V, Stürmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H. Patient delay and stage of diagnosis among breast cancer patients in Germany: a population based study. Br J Cancer. 2002;86(7):1034–40. https://doi.org/10.1038/SJ.BJC.6600209.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen SC, Hung YC, Kung PT, Yang WH, Wang YH, Tsai WC. Factors involved in the delay of treatment initiation for cervical cancer patients: a nationwide population-based study. Medicine. 2016. https://doi.org/10.1097/MD.0000000000004568.

Article  PubMed  PubMed Central  Google Scholar 

“Data for Thailand, Malaysia, Indonesia, Singapore, Philippines, Vietnam | Data.” https://data.worldbank.org/?locations=TH-MY-ID-SG-PH-VN Accessed 22 Jan 2023

Toh ZQ, Licciardi PV, Russell FM, Garland SM, Batmunkh T, Mulholland EK. Cervical cancer prevention through HPV vaccination in low- and middle-income countries in Asia. Asian Pac J Cancer Prev. 2017;18(9):2339. https://doi.org/10.22034/APJCP.2017.18.9.2339.

Article  PubMed  PubMed Central  Google Scholar 

Vinh-Hung V, et al. Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer. 2007;7(1):1–13. https://doi.org/10.1186/1471-2407-7-164/FIGURES/4.

Article  Google Scholar 

Chen SW, Liang JA, Yang SN, Ko HL, Lin FJ. The adverse effect of treatment prolongation in cervical cancer byhigh-dose-rate intracavitary brachytherapy. Radiother Oncol. 2003;67(1):69–76. https://doi.org/10.1016/S0167-8140(02)00439-5.

Article  PubMed  Google Scholar 

Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. The BMJ. 2021. https://doi.org/10.1136/BMJ.N71.

Article  PubMed  PubMed Central  Google Scholar 

Thokanit NS, Kosalaraksa P, Jitkasikorn P, Thonkamdee T, Promchana S, Wilailak S. A prognostic study of patients with cervical cancer and HIV/AIDS in Bangkok, Thailand. Gynecol Oncol Rep. 2020;34: 100669. https://doi.org/10.1016/J.GORE.2020.100669.

Article  PubMed  PubMed Central  Google Scholar 

Ruengkhachorn I, Leelaphatanadit C, Therasakvichya S, Hunnangkul S. Oncologic outcomes of stage IVB or persistent or recurrent cervical carcinoma patients treated with chemotherapy at Siriraj hospital: Thailand’s largest tertiary referral center. Int J Gynecol Cancer. 2016;26(6):1154–61. https://doi.org/10.1097/IGC.0000000000000712.

Article  PubMed  PubMed Central  Google Scholar 

Suprasert P, Charoenkwan K, Cheewakriangkrai C. Outcomes of advanced and recurrent cervical cancer treated with cisplatin and generic topotecan: retrospective analysis in a tertiary care hospital in Thailand. J Gynecol Oncol. 2010;21(4):237–40. https://doi.org/10.3802/JGO.2010.21.4.237.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tharavichitkul E, et al. Survival outcome of cervical cancer patients treated by image-guided brachytherapy: a ‘real world’ single center experience in Thailand from 2008 to 2018. J Radiat Res. 2022;63(4):657–65. https://doi.org/10.1093/JRR/RRAC025.

Article  PubMed  PubMed Central  Google Scholar 

Tharavichitkul E, et al. The effects of two HDR brachytherapy schedules in locally advanced cervical cancer treated with concurrent chemoradiation: a study from Chiang Mai, Thailand. J Radiat Res. 2012;53(2):281–7. https://doi.org/10.1269/JRR.11038.

Article  PubMed  Google Scholar 

Juhan N, Abd Razak N, Zulina Zubairi Y, Naeem Khattak M, Nyi Naing N. Survey of patients with cervical cancer in hospital universitisains Malaysia: survival data analysis with time-dependent covariate. Iran J Public Health. 2013;42(9):980.

PubMed  PubMed Central  Google Scholar 

Muhamad NA, et al. Survival rates of cervical cancer patients in Malaysia. Asian Pac J Cancer Prev. 2015;16(7):3067–72. https://doi.org/10.7314/APJCP.2015.16.7.3067.

Article  PubMed  Google Scholar 

Zubaidah Z, et al. The 3 year survival rate of cervical cancer patients at refferral hospital in Southeast Sumatra, Indonesia. Urnal Berk Epidemiol. 2022;10(2):121–9.

Article  Google Scholar 

Schellekens MC, et al. Prevalence of single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia. Gynecol Oncol. 2004;93(1):49–53. https://doi.org/10.1016/j.ygyno.2003.12.015.

Article  PubMed  Google Scholar 

Gondhowiardjo S, et al. Treatment delay of cancer patients in Indonesia: a reflection from a national referral hospital. Med J Indones. 2021;30(2):129–37. https://doi.org/10.13181/MJI.OA.204296.

Article  Google Scholar 

Pratiwi SE, Trianto HF, Fatinah NN, Ilmiawan MI, Fitrianingrum I, Lestari D. The profile of cervical cancer patients at soedarso hospital. Indones J Cancer. 2022;16(1):33–8. https://doi.org/10.33371/IJOC.V16I1.845.

Article  Google Scholar 

Sari NPWP. Women living with breast and cervical cancer in the community: the face of Surabaya nowadays. Indones J Cancer. 2019;12(4):116–22. https://doi.org/10.33371/IJOC.V12I4.605.

Article  Google Scholar 

Mahendra INB. The characteristics of cervical cancer patients who underwent a radical hysterectomy at Sanglah Hospital Denpasar in 2015. Bali Medcal J. 2016;5(2):237–9. https://doi.org/10.15562/BMJ.V5I2.208.

Article  Google Scholar 

Puspitasari IM, Legianawati D, Sinuraya RK, Suwantika AA. Cost-effectiveness analysis of chemoradiation and radiotherapy treatment for stage IIB and IIIB cervical cancer patients. Int J Womens Health. 2021;13:221–9. https://doi.org/10.2147/IJWH.S289781.

Article  PubMed  PubMed Central  Google Scholar 

Nabandith V, et al. First trial of cervical cytology in healthy women of urban Laos using by self-sampling instrument. Asian Pac J Cancer Prev. 2012;13(9):4665–7. https://doi.org/10.7314/APJCP.2012.13.9.4665.

Article  PubMed  Google Scholar 

Khor TH, Tuan JKL, Hee SW, Tham IWK. Radical radiotherapy with high-dose-rate brachytherapy for uterine cervix cancer long-term results. Australas Radiol. 2007;51(6):570–7. https://doi.org/10.1111/J.1440-1673.2007.01895.X.

Article  CAS